Clal Insurance Enterprises Holdings Ltd Has $61.88 Million Holdings in SPDR S&P Biotech ETF $XBI

Clal Insurance Enterprises Holdings Ltd decreased its stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 29.9% in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 484,500 shares of the exchange traded fund’s stock after selling 206,500 shares during the period. Clal Insurance Enterprises Holdings Ltd owned approximately 0.76% of SPDR S&P Biotech ETF worth $61,885,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also made changes to their positions in the stock. Cassaday & Co Wealth Management LLC bought a new stake in SPDR S&P Biotech ETF in the 1st quarter valued at $85,000. Balefire LLC increased its holdings in SPDR S&P Biotech ETF by 1.3% during the 1st quarter. Balefire LLC now owns 13,637 shares of the exchange traded fund’s stock worth $1,742,000 after purchasing an additional 178 shares in the last quarter. Parallel Advisors LLC raised its stake in shares of SPDR S&P Biotech ETF by 1.2% in the 1st quarter. Parallel Advisors LLC now owns 27,604 shares of the exchange traded fund’s stock valued at $3,526,000 after purchasing an additional 317 shares during the period. PeakShares LLC raised its stake in shares of SPDR S&P Biotech ETF by 5.2% in the 1st quarter. PeakShares LLC now owns 1,684 shares of the exchange traded fund’s stock valued at $215,000 after purchasing an additional 84 shares during the period. Finally, Independent Financial Group LLC acquired a new stake in shares of SPDR S&P Biotech ETF in the 1st quarter valued at about $888,000.

SPDR S&P Biotech ETF Price Performance

Shares of SPDR S&P Biotech ETF stock opened at $154.50 on Wednesday. The firm has a market cap of $10.37 billion, a price-to-earnings ratio of 11.47 and a beta of 0.82. The stock’s 50-day moving average is $143.17 and its 200-day moving average is $132.89. SPDR S&P Biotech ETF has a one year low of $84.39 and a one year high of $165.71.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.